https://orcid.org/0000-0003-2717-5364
Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rishi Chandiramani, Alessandro Spirito, James W. Johnson, Adhya Mehta, Birgit Vogel, Robert T. Faillace & Roxana Mehran. (2023) Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects. Expert Review of Cardiovascular Therapy 21:5, pages 311-328.
Read now
Read now
Daniel K. Afosah, Edward Ofori, Madhusoodanan Mottamal & Rami A. Al-Horani. (2022) Factor IX(a) inhibitors: an updated patent review (2003-present). Expert Opinion on Therapeutic Patents 32:4, pages 381-400.
Read now
Read now
Articles from other publishers (11)
Abhishek Goel, Harsha Tathireddy, Si-Han Wang, Helen H. Vu, Cristina Puy, Monica T. Hinds, David Zonies, Owen J.T. McCarty & Joseph J. Shatzel. (2023) Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis. Seminars in Thrombosis and Hemostasis.
Crossref
Crossref
Rowan Frunt, Hinde El Otmani, Bubacarr Gibril Kaira, Steven de Maat & Coen Maas. (2022) Factor XII Explored with AlphaFold - Opportunities for Selective Drug Development. Thrombosis and Haemostasis 123:02, pages 177-185.
Crossref
Crossref
Jesper Strandberg, Inger Lise Gade, Yaseelan Palarasah, Jørgen Brodersen Gram, Søren Risom Kristensen & Johannes Jakobsen Sidelmann. (2023) Combined oral contraceptives may activate the contact system in healthy women. Research and Practice in Thrombosis and Haemostasis 7:2, pages 100118.
Crossref
Crossref
Lukas Imberg, Simon Platte, Catharina Erbacher, Constantin G. Daniliuc, Svetlana A. Kalinina, Wolfgang Dörner, Antti Poso, Uwe Karst & Dmitrii V. Kalinin. (2022) Amide-functionalized 1,2,4-Triazol-5-amines as Covalent Inhibitors of Blood Coagulation Factor XIIa and Thrombin. ACS Pharmacology & Translational Science 5:12, pages 1318-1347.
Crossref
Crossref
Ignacio Barriuso, Fernando Worner & Gemma Vilahur. (2022) Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment. Journal of Cardiovascular Development and Disease 9:11, pages 397.
Crossref
Crossref
Calvin Dunker, Lukas Imberg, Alena I. Siutkina, Catharina Erbacher, Constantin G. Daniliuc, Uwe Karst & Dmitrii V. Kalinin. (2022) Pyrazole-Based Thrombin Inhibitors with a Serine-Trapping Mechanism of Action: Synthesis and Biological Activity. Pharmaceuticals 15:11, pages 1340.
Crossref
Crossref
Sheng-Chieh Chou, Ching-Yeh Lin, Hsuan-Yu Lin, Chen-Hsueh Pai, Cheng-Ye Yu, Su-Feng Kuo, Jen-Shiou Lin, Po-Te Lin, Mei-Hua Hung, Han-Ni Hsieh, Hsiang-Chun Liu & Ming-Ching Shen. (2022) Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation. International Journal of Hematology 116:4, pages 528-533.
Crossref
Crossref
Valeria Cortesi, Genny Raffaeli, Giacomo S. Amelio, Ilaria Amodeo, Silvia Gulden, Francesca Manzoni, Gaia Cervellini, Andrea Tomaselli, Marta Colombo, Gabriella Araimo, Andrea Artoni, Stefano Ghirardello, Fabio Mosca & Giacomo Cavallaro. (2022) Hemostasis in neonatal ECMO. Frontiers in Pediatrics 10.
Crossref
Crossref
Junwei Lan, Tianbao Zeng, Sheng Liu, Juhong Lan & Lijun Qian. (2022) Noonan syndrome with RAF1 gene mutations in a newborn with cerebral haemorrhage. European Journal of Medical Research 27:1.
Crossref
Crossref
Michael P. Schön. (2022) Die Zecke und ich: Parasiten‐Wirt‐Interaktionen zwischen Zecken und Menschen. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:6, pages 818-855.
Crossref
Crossref
Michael P. Schön. (2022) The tick and I: Parasite‐host interactions between ticks and humans. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:6, pages 818-853.
Crossref
Crossref